Revoshield

Revoshield is a dehydrated amniotic membrane allograft developed and distributed by Halo Biologics. Classified as a Human Cells, Tissues, and Cellular and Tissue-Based Product (HCT/P) and regulated as a medical device, it is designed for use as a biological barrier and protective covering in surgical and wound care applications. The product is derived from donated human placental tissue and processed to preserve the natural extracellular matrix (ECM), which includes essential proteins such as collagen, fibronectin, and laminin. Revoshield serves as a scaffold for cellular attachment and proliferation, facilitating the body's natural healing process while providing a physical barrier that reduces the risk of adhesions and inflammation in the surgical site or wound bed.

Brand names

Revoshield

Other names

Revoshield Amniotic MembraneRevoshield HCT/P